Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 17, 2021 - Issue
Submit an article Journal homepage
386
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes

Salome Landolt1 Institute of Primary Care, University of Zürich, University Hospital Zürich, Zürich, Switzerland
,
Thomas Rosemann1 Institute of Primary Care, University of Zürich, University Hospital Zürich, Zürich, SwitzerlandORCID Iconhttps://orcid.org/0000-0002-6436-6306
ORCID Icon,
Eva Blozik1 Institute of Primary Care, University of Zürich, University Hospital Zürich, Zürich, Switzerland;2 Department of Health Sciences, Helsana Insurance Group, Zürich, SwitzerlandORCID Iconhttps://orcid.org/0000-0002-0620-6873
ORCID Icon,
Beat Brüngger2 Department of Health Sciences, Helsana Insurance Group, Zürich, Switzerland
&
Carola A Huber1 Institute of Primary Care, University of Zürich, University Hospital Zürich, Zürich, Switzerland;2 Department of Health Sciences, Helsana Insurance Group, Zürich, SwitzerlandCorrespondence[email protected]
Pages 1021-1034 | Published online: 12 Apr 2021

Figures & data

Figure 1 Extrapolated prevalence of benzodiazepine use in the Swiss adult population by sex and age in 2018.

Figure 1 Extrapolated prevalence of benzodiazepine use in the Swiss adult population by sex and age in 2018.

Figure 2 Extrapolated prevalence of Z-drug use in the Swiss adult population by sex and age in 2018.

Figure 2 Extrapolated prevalence of Z-drug use in the Swiss adult population by sex and age in 2018.

Figure 3 Extrapolated prevalence of benzodiazepine and/or Z-drug use in the Swiss adult population by sex and age in 2018.

Figure 3 Extrapolated prevalence of benzodiazepine and/or Z-drug use in the Swiss adult population by sex and age in 2018.

Table 1 Characteristics of the Study Population with and without Benzodiazepine and Z-Drug Use in 2018

Table 2 Number of Prescriptions and Prescription by Type of Provider among Benzodiazepine and Z-Drug User in 2018

Table 3 Number of Prescriptions and Prescription by Type of Provider among Benzodiazepine Short- and Long-Acting User in 2018

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.